NFKB1 and neoplasm: Accordingly, NF-κB activation in non-malignant tumor-associated cells has been shown to amplify the production of cytokines and other specialized effectors that promote tumor-cell proliferation, invasion and therapy resistance, while suppressing anti-tumor immune responses (33).